Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Mayne Pharma Group ( (AU:MYX) ) is now available.
Mitsubishi UFJ Financial Group, through its subsidiary First Sentier Investors Holdings Pty Limited, has acquired a substantial holding in Mayne Pharma Group Ltd. This acquisition grants them significant voting power and influence over the company’s operations, reflecting a strategic investment move that could impact Mayne Pharma’s market positioning and stakeholder interests.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 936,280
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$407.9M
Learn more about MYX stock on TipRanks’ Stock Analysis page.